Semir Vranić

Citat de

	Toate	Din 2020
Referințe bibliografice	9204	7101
h-index	46	40
i10-index	143	133

1700

850

425

1275

20112012201320142015201620172018201920202021202220232024202566 72 93 72 173 247 275 391 546 907 1280 1532 1449 1617 293

Acces public

Afișați-le pe toate

11 articole

0 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Ala-Eddin Al Moustafa, PhDProf., College of Medicine, Qatar University & Adjunct Prof., Oncology Dept., McGill UniversityAdresă de e-mail confirmată pe qu.edu.qa
Faruk SkenderiDept. of Pathology, Sarajevo School of Science and TechnologyAdresă de e-mail confirmată pe biomolbiomed.com
Zlatan ZvizdicFull Professor of Pediatric Surgery at the University of Sarajevo, Bosnia and HerzegovinaAdresă de e-mail confirmată pe mf.unsa.ba
Ljiljana SermanUniversity of Zagreb, School of Medicine; ProfessorAdresă de e-mail confirmată pe mef.hr
Anna SapinoCandiolo Cancer Center, FPO-IRCCS, Candiolo, Italy and Dept. of Medical Sciences, University ofAdresă de e-mail confirmată pe ircc.it
Daniel Von HoffChief Scientific Officer US Oncology, Chief Scientific Officer TGen, Distinguished Professor MayoAdresă de e-mail confirmată pe tgen.org
Semir BeslijaProfessor of Oncology, KCUS, University of SarajevoAdresă de e-mail confirmată pe mf.unsa.ba
Božo KrušlinProfessor of Pathology, Dpt of Pathology, School of Medicine, University of Zagreb, CroatiaAdresă de e-mail confirmată pe mef.hr
Ivan DamjanovUniversity of Kansas School of MedicineAdresă de e-mail confirmată pe kumc.edu
Fadila SerdarevicErasmus MCAdresă de e-mail confirmată pe erasmusmc.nl
Amina Kurtovic-KozaricInternational Burch University; Department of Genetics and BioengineeringAdresă de e-mail confirmată pe ibu.edu.ba
Gábor CserniBács-Kiskun County Teaching Hosp. & University of Szeged, Faculty of Medicine, Institute ofAdresă de e-mail confirmată pe kmk.hu
Pierre HainautProfessor, Cancer Biology, University Grenoble Alpes and Director, Institute for AdvancedAdresă de e-mail confirmată pe univ-grenoble-alpes.fr

Urmăriți

Semir Vranić

Alte numeSemir Vranic

CMED, Qatar University & Academy of Sciences and Arts of Bosnia&Herzegovina

Adresă de e-mail confirmată pe qu.edu.qa - Pagina de pornire

Pathology histopathology molecular pathology cancer diagnostics


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
The role of the Hedgehog signaling pathway in cancer: A comprehensive review AM Skoda, D Simovic, V Karin, V Kardum, S Vranic, L Serman Bosnian journal of basic medical sciences, 2018	763	2018
The 2019 WHO classification of tumours of the breast PH Tan, I Ellis, K Allison, E Brogi, SB Fox, S Lakhani, AJ Lazar, EA Morris, ... Histopathology 77 (2), 2020	734	2020
Programmed cell death 1 (PD-1) and its ligand (PD-L1) in common cancers and their correlation with molecular cancer type Z Gatalica, C Snyder, T Maney, A Ghazalpour, DA Holterman, N Xiao, ... Cancer epidemiology, biomarkers & prevention 23 (12), 2965-2970, 2014	578	2014
Molecular characterization of cancers with NTRK gene fusions Z Gatalica, J Xiu, J Swensen, S Vranic Modern pathology 32 (1), 147-153, 2019	500	2019
Molecular mechanisms of colon cancer progression and metastasis: recent insights and advancements A Malki, RA ElRuz, I Gupta, A Allouch, S Vranic, AE Al Moustafa International journal of molecular sciences 22 (1), 130, 2020	370	2020
WHO classification of tumours WHO Classification of Tumours Editorial Board Digestive system tumours, 2019	202	2019
A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells XT Zhang, LG Kang, L Ding, S Vranic, Z Gatalica, ZY Wang Oncogene 30 (7), 770-780, 2011	193	2011
High microsatellite instability (MSI-H) colorectal carcinoma: a brief review of predictive biomarkers in the era of personalized medicine Z Gatalica, S Vranic, J Xiu, J Swensen, S Reddy Familial cancer 15 (3), 405-412, 2016	190	2016
PD-L1 status in breast cancer: Current view and perspectives S Vranic, FS Cyprian, Z Gatalica, J Palazzo Seminars in cancer biology 72, 146-154, 2021	140	2021
EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast S Vranic, O Tawfik, J Palazzo, N Bilalovic, E Eyzaguirre, LMJ Lee, ... Modern pathology 23 (5), 644-653, 2010	131	2010
Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1 U Joneja, S Vranic, J Swensen, R Feldman, W Chen, J Kimbrough, ... Journal of clinical pathology, jclinpath-2016-203874, 2017	124	2017
Targeted immunotherapy with a checkpoint inhibitor in combination with chemotherapy: A new clinical paradigm in the treatment of triple-negative breast cancer FS Cyprian, S Akhtar, Z Gatalica, S Vranic Bosnian Journal of Basic Medical Sciences 19 (3), 227, 2019	123	2019
Predictive biomarker profiling of> 6000 breast cancer patients shows heterogeneity in TNBC, with treatment implications SZ Millis, Z Gatalica, J Winkler, S Vranic, J Kimbrough, S Reddy, ... Clinical breast cancer 15 (6), 473-481. e3, 2015	119	2015
Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy Z Gatalica, J Xiu, J Swensen, S Vranic European journal of cancer 94, 179-186, 2018	105	2018
Apocrine carcinoma of the breast: a comprehensive review S Vranic, F Schmitt, A Sapino, JL Costa, S Reddy, M Castro, Z Gatalica F. Hernández y Juan F. Madrid. Universidad de Murcia. Departamento de …, 2013	102	2013
Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1 Z Gatalica, N Bilalovic, JP Palazzo, RP Bender, J Swensen, SZ Millis, ... Oncotarget 6 (23), 19819, 2015	93	2015
Molecular profiling of infiltrating urothelial carcinoma of bladder and nonbladder origin SZ Millis, D Bryant, G Basu, R Bender, S Vranic, Z Gatalica, NJ Vogelzang Clinical genitourinary cancer 13 (1), e37-e49, 2015	92	2015
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases Z Gatalica, SZ Millis, S Vranic, R Bender, GD Basu, A Voss, DD Von Hoff Oncotarget 5 (23), 12440, 2014	88	2014
Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17 S Vranic, B Teruya, S Repertinger, P Ulmer, J Hagenkord, Z Gatalica Cancer 117 (1), 48-53, 2011	88	2011
ER-α36, a novel isoform of ER-α66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast S Vranic, Z Gatalica, H Deng, S Frkovic-Grazio, LMJ Lee, O Gurjeva, ... Journal of clinical pathology, jcp. 2010.082776, 2011	84	2011

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori